Prevenar 13 Inj

The active compound in Prevenar 13 (also known as Prevnar 13) is a pneumococcal polysaccharide conjugate vaccine. It contains purified capsular polysaccharides from 13 strains of the bacterium Streptococcus pneumoniae (pneumococcus). These polysaccharides are individually conjugated to a carrier protein called CRM197, which is a non-toxic variant of diphtheria toxin. This conjugation enhances the immune response, making the vaccine more effective, especially in young children. Derived from the c

• ✓PCV13 by Pfizer protecting against 13 pneumococcal serotypes via CRM197 conjugation
• ✓Broadest pneumococcal conjugate coverage for infants and young children
• ✓Prevents invasive pneumococcal disease, pneumonia, meningitis, and acute otitis media
• ✓Recommended for routine pediatric immunization and adults over 65

Requires 4 doses